van der Maas NA - Search Results

1

Comparison of the tolerability of an acellular pertussis-containing vaccine given as the fifth booster dose in differently primed children.

Kemmeren JM, Timmer SS, van der Maas NA, de Melker HE. Kemmeren JM, et al. Among authors: van der maas na. Vaccine. 2011 Jun 10;29(26):4373-7. doi: 10.1016/j.vaccine.2011.04.009. Epub 2011 Apr 22. Vaccine. 2011. PMID: 21514347

2

Performance of the Brighton collaboration case definition for hypotonic-hyporesponsive episode (HHE) on reported collapse reactions following infant vaccinations in the Netherlands.

Vermeer-de Bondt PE, Dzaferagić A, David S, van der Maas NA. Vermeer-de Bondt PE, et al. Among authors: van der maas na. Vaccine. 2006 Nov 30;24(49-50):7066-70. doi: 10.1016/j.vaccine.2006.07.008. Epub 2006 Jul 24. Vaccine. 2006. PMID: 16935396

3

Adverse events following booster doses of diphtheria-tetanus-inactivated poliovirus and acellular pertussis vaccines for 4-year-old children in The Netherlands.

Bults M, Kemmeren JM, van der Maas NA. Bults M, et al. Among authors: van der maas na. Vaccine. 2007 Jul 20;25(29):5272-7. doi: 10.1016/j.vaccine.2007.05.017. Epub 2007 Jun 4. Vaccine. 2007. PMID: 17573165

4

Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands.

Boot HJ, Wallenburg I, de Melker HE, Mangen MJ, Gerritsen AA, van der Maas NA, Berkhof J, Meijer CJ, Kimman TG. Boot HJ, et al. Among authors: van der maas na. Vaccine. 2007 Aug 14;25(33):6245-56. doi: 10.1016/j.vaccine.2007.05.061. Epub 2007 Jun 21. Vaccine. 2007. PMID: 17630049

5

[Safety surveillance in the National Vaccination Programme; fewer adverse events with the DTP-IPV-Hib vaccine after the transition to an acellular pertussis component in 2005].

van der Maas NA, David S, Kemmeren JM, Vermeer-de Bondt PE. van der Maas NA, et al. Ned Tijdschr Geneeskd. 2007 Dec 8;151(49):2732-7. Ned Tijdschr Geneeskd. 2007. PMID: 18225797 Dutch.

6

The effect of age and dose number on the risk of collapse (hypotonic-hyporesponsive episode) after pertussis vaccination.

Vermeer-de Bondt PE, van der Maas NA. Vermeer-de Bondt PE, et al. Among authors: van der maas na. Pediatr Infect Dis J. 2008 Apr;27(4):355-7. doi: 10.1097/INF.0b013e318162a127. Pediatr Infect Dis J. 2008. PMID: 18379375

7

Assessing the introduction of universal rotavirus vaccination in the Netherlands.

Zomer TP, van Duynhoven YT, Mangen MJ, van der Maas NA, Vennema H, Boot H, de Melker HE. Zomer TP, et al. Among authors: van der maas na, van duynhoven yt. Vaccine. 2008 Jul 4;26(29-30):3757-64. doi: 10.1016/j.vaccine.2008.04.039. Epub 2008 May 5. Vaccine. 2008. PMID: 18514975

8

Discolored leg syndrome after vaccination--descriptive epidemiology.

Kemmeren JM, Vermeer-de Bondt PE, van der Maas NA. Kemmeren JM, et al. Among authors: van der maas na. Eur J Pediatr. 2009 Jan;168(1):43-50. doi: 10.1007/s00431-008-0707-0. Epub 2008 Jun 11. Eur J Pediatr. 2009. PMID: 18546020

9

Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands.

David S, Vermeer-de Bondt PE, van der Maas NA. David S, et al. Among authors: van der maas na. Vaccine. 2008 Oct 29;26(46):5883-7. doi: 10.1016/j.vaccine.2008.07.105. Epub 2008 Sep 4. Vaccine. 2008. PMID: 18775463

10

Acute cerebellar ataxia in the Netherlands: a study on the association with vaccinations and varicella zoster infection.

van der Maas NA, Bondt PE, de Melker H, Kemmeren JM. van der Maas NA, et al. Vaccine. 2009 Mar 18;27(13):1970-3. doi: 10.1016/j.vaccine.2009.01.019. Epub 2009 Jan 30. Vaccine. 2009. PMID: 19186201

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters